Skip to main content

ROYCE & ASSOCIATES LP

Position in GILD — Gilead Sciences, Inc.

CIK 906304 New York, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,663,860
-$377,870 QoQ
Shares Held
29,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#661
of 2,265 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $4,930,879 across 2 Drug Manufacturers - General names. GILD ranks #1 (74.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GILD
Gilead Sciences, Inc.
This page
29,000 $3,663,860

All Filings in GILD

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,663,860 29,000
2026-03-31 $4,041,730 29,000
2025-12-31 $5,216,450 42,500
2025-09-30 $4,717,500 42,500
2025-06-30 $5,432,630 49,000
2025-03-31 $7,619,400 68,000
2024-12-31 $6,465,900 70,000
2024-09-30 $6,707,200 80,000
2024-06-30 $5,488,800 80,000
2024-03-31 $4,468,250 61,000
2023-12-31 $4,698,580 58,000
2023-09-30 $4,346,520 58,000
2023-06-30 $4,123,245 53,500
2023-03-31 $3,235,830 39,000
2022-12-31 $2,317,950 27,000
2022-09-30 $1,665,630 27,000
2022-06-30 $1,668,870 27,000
2022-03-31 $1,307,900 22,000
2021-09-30 $3,806,825 54,500
2021-06-30 $3,856,160 56,000
2021-03-31 $3,586,965 55,500
2020-12-31 $1,165,200 20,000